Clinical Trial Update: Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine [Phase 3]

View source ↗

Summary

Phase 3 study evaluating oral atogepant for episodic migraine in adult Japanese participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qulipta (atogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Phase 3 | Status: COMPLETED